Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytrx Corp (OP: CYTR ) N/A UNCHANGED Last Price Updated: 1:53 PM EDT, Oct 5, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cytrx Corp < Previous 1 2 Next > CytRx Notes Orphazyme’s Regulatory Update from the FDA on Arimoclomol for Niemann-Pick Disease Type C June 18, 2021 From CytRx Corporation Via Business Wire Orphazyme Wild Party At Risk As FDA Rejects Its Rare Neurodegenerative Disease Drug June 18, 2021 Orphazyme A/S (NASDAQ: ORPH) shares, which have been extremely volatile of late, could come under pressure Friday following a regulatory setback. What Happened:... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme June 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... Via Benzinga Exposures COVID-19 A Look At Orpahzyme's Volatility Ahead Of Thursday's PDUFA Catalyst June 16, 2021 After sobering down in the past three sessions, shares of Danish biopharma Orphazyme A/S (NASDAQ: ORPH) have taken off yet again. The Curious Case of The ‘Orphazyme Rally:... Via Benzinga Why Novavax, Orphazyme, Avenue Therapeutics Shares Are Moving Monday June 14, 2021 Novavax, Inc. (NASDAQ: NVAX), Orphazyme A/S (NASDAQ: ORPH) and Avenue Therapeutics, Inc. (NASDAQ: ATXI) are among the biggest movers among biopharma stocks Monday. Novavax Finally... Via Benzinga The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs June 13, 2021 Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in the form of approval... Via Talk Markets Exposures Product Safety The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs June 13, 2021 Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in... Via Benzinga Exposures Product Safety CytRx to Present at Upcoming Investor Conferences June 02, 2021 From CytRx Corporation Via Business Wire Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates June 01, 2021 The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive... Via Benzinga Exposures Product Safety CytRx Comments on Quarterly Results and Year-to-Date Progress May 13, 2021 From CytRx Corporation Via Business Wire CytRx Notes Topline Data From Trial of Arimoclomol in Amyotrophic Lateral Sclerosis May 07, 2021 From CytRx Corporation Via Business Wire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
